{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T05:54:15Z","timestamp":1774158855298,"version":"3.50.1"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"crossref","award":["142\/13"],"award-info":[{"award-number":["142\/13"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"crossref","award":["1439\/14"],"award-info":[{"award-number":["1439\/14"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","award":["590531"],"award-info":[{"award-number":["590531"]}],"id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","award":["1326239"],"award-info":[{"award-number":["1326239"]}],"id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001594","name":"Dysautonomia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0211602","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T13:47:44Z","timestamp":1553003264000},"page":"e0211602","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combinatorial treatment increases IKAP levels in human cells generated from Familial Dysautonomia patients"],"prefix":"10.1371","volume":"14","author":[{"given":"Sivan","family":"Yannai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Zonszain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Donyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6674-0931","authenticated-orcid":true,"given":"Gil","family":"Ast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/mus.10499","article-title":"Familial dysautonomia","volume":"29","author":"FB Axelrod","year":"2004","journal-title":"Muscle Nerve"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pneurobio.2016.06.003","article-title":"Familial dysautonomia: History, genotype, phenotype and translational research","volume":"152","author":"L Norcliffe-Kaufmann","year":"2017","journal-title":"Prog Neurobiol"},{"key":"ref3","article-title":"Familial Dysautonomia: Mechanisms and Models","author":"P Dietrich","year":"2016","journal-title":"Genet Mol Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1086\/318810","article-title":"Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia","volume":"68","author":"SA Slaugenhaupt","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/318808","article-title":"Familial dysautonomia is caused by mutations of the IKAP gene","volume":"68","author":"SL Anderson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0959-437X(02)00303-9","article-title":"Familial dysautonomia","volume":"12","author":"SA Slaugenhaupt","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/109065703322146830","article-title":"Screening for familial dysautonomia in Israel: evidence for higher carrier rate among Polish Ashkenazi Jews","volume":"7","author":"O Lehavi","year":"2003","journal-title":"Genet Test"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1086\/368263","article-title":"Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia","volume":"72","author":"MP Cuajungco","year":"2003","journal-title":"Am J Hum Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1261\/rna.5196404","article-title":"Comparative analysis detects dependencies among the 5' splice-site positions","volume":"10","author":"I Carmel","year":"2004","journal-title":"Rna"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10286-017-0438-2","article-title":"Animal and cellular models of familial dysautonomia","volume":"27","author":"F Lefcort","year":"2017","journal-title":"Clin Auton Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1074\/jbc.M110445200","article-title":"Purification and characterization of the human elongator complex","volume":"277","author":"NA Hawkes","year":"2002","journal-title":"J Biol Chem"},{"key":"ref12","article-title":"Dimerization of elongator protein 1 is essential for Elongator complex assembly","author":"H Xu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molcel.2006.04.017","article-title":"Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia","volume":"22","author":"P Close","year":"2006","journal-title":"Mol Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e113428","DOI":"10.1371\/journal.pone.0113428","article-title":"Involvement of IKAP in peripheral target innervation and in specific JNK and NGF signaling in developing PNS neurons","volume":"9","author":"A Abashidze","year":"2014","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"31918","DOI":"10.1074\/jbc.M200719200","article-title":"A novel specific role for I kappa B kinase complex-associated protein in cytosolic stress signaling","volume":"277","author":"C Holmberg","year":"2002","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.molcel.2006.07.031","article-title":"Elevated levels of two tRNA species bypass the requirement for elongator complex in transcription and exocytosis","volume":"24","author":"A Esberg","year":"2006","journal-title":"Mol Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbrc.2014.10.116","article-title":"Familial dysautonomia (FD) patients have reduced levels of the modified wobble nucleoside mcm(5)s(2)U in tRNA","volume":"454","author":"T Karlsborn","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/hmg\/ddr036","article-title":"IKAP\/Elp1 involvement in cytoskeleton regulation and implication for familial dysautonomia","volume":"20","author":"D Cheishvili","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e32050","DOI":"10.1371\/journal.pone.0032050","article-title":"IKAP\/Elp1 is required in vivo for neurogenesis and neuronal survival, but not for neural crest migration","volume":"7","author":"BJ Hunnicutt","year":"2012","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/1673-5374.205082","article-title":"Phosphatidylserine improves axonal transport by inhibition of HDAC and has potential in treatment of neurodegenerative diseases","volume":"12","author":"S Naftelberg","year":"2017","journal-title":"Neural Regen Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/hmg\/ddm157","article-title":"IKAP\/hELP1 deficiency in the cerebrum of familial dysautonomia patients results in down regulation of genes involved in oligodendrocyte differentiation and in myelination","volume":"16","author":"D Cheishvili","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e94612","DOI":"10.1371\/journal.pone.0094612","article-title":"IKAP deficiency in an FD mouse model and in oligodendrocyte precursor cells results in downregulation of genes involved in oligodendrocyte differentiation and myelin formation","volume":"9","author":"D Cheishvili","year":"2014","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/MCB.01313-08","article-title":"Loss of mouse Ikbkap, a subunit of elongator, leads to transcriptional deficits and embryonic lethality that can be rescued by human IKBKAP","volume":"29","author":"YT Chen","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1242\/dev.107797","article-title":"A neuron autonomous role for the familial dysautonomia gene ELP1 in sympathetic and sensory target tissue innervation","volume":"141","author":"MZ Jackson","year":"2014","journal-title":"Development"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1093\/nar\/gky249","article-title":"Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice","volume":"46","author":"R Sinha","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7938","DOI":"10.1093\/nar\/gky395","article-title":"Blocking of an intronic splicing silencer completely rescues IKBKAP exon 20 splicing in familial dysautonomia patient cells","volume":"46","author":"GH Bruun","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/hmg\/ddy151","article-title":"Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model","volume":"27","author":"I Donadon","year":"2018","journal-title":"Hum Mol Genet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1073\/pnas.1415525112","article-title":"Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia","volume":"112","author":"M Yoshida","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","unstructured":"Salani M, Urbina F, Brenner A, Morini E, Shetty R, Gallagher CS, et al. (2018) Development of a Screening Platform to Identify Small Molecules That Modify ELP1 Pre-mRNA Splicing in Familial Dysautonomia. SLAS Discov: 2472555218792264."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e15884","DOI":"10.1371\/journal.pone.0015884","article-title":"Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells","volume":"5","author":"H Keren","year":"2010","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/hmg\/ddt126","article-title":"Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model","volume":"22","author":"R Bochner","year":"2013","journal-title":"Hum Mol Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e1006486","DOI":"10.1371\/journal.pgen.1006486","article-title":"Phosphatidylserine Ameliorates Neurodegenerative Symptoms and Enhances Axonal Transport in a Mouse Model of Familial Dysautonomia","volume":"12","author":"S Naftelberg","year":"2016","journal-title":"PLoS Genet"},{"key":"ref33","article-title":"Phosphatidylserine enhances IKBKAP transcription by activating the MAPK\/ERK signaling pathway","author":"M Donyo","year":"2016","journal-title":"Hum Mol Genet"},{"key":"ref34","unstructured":"Salani M, Norcliffe-Kaufmann L, Martinez J, Morini E, Axelrod F, Slaugenhaupt S. Phosphatidylserine: A potential gene modifying therapy for Familial Dysautonomia?; 2013; Boston USA."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/hmg\/ddh046","article-title":"Rescue of a human mRNA splicing defect by the plant cytokinin kinetin","volume":"13","author":"SA Slaugenhaupt","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1203\/PDR.0b013e31822e1825","article-title":"Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia","volume":"70","author":"FB Axelrod","year":"2011","journal-title":"Pediatr Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1203\/PDR.0b013e318194fd52","article-title":"Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing","volume":"65","author":"G Gold-von Simson","year":"2009","journal-title":"Pediatr Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nrn1989","article-title":"Histone deacetylase inhibitors as therapeutics for polyglutamine disorders","volume":"7","author":"R Butler","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"ref39","first-page":"393","article-title":"Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells","volume":"25","author":"C Puppin","year":"2011","journal-title":"Oncol Rep"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"AJ de Ruijter","year":"2003","journal-title":"Biochem J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"N Khan","year":"2008","journal-title":"Biochem J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/13543784.17.2.169","article-title":"Histone deacetylase inhibitors: possible implications for neurodegenerative disorders","volume":"17","author":"E Hahnen","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2009.11.025","article-title":"The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties","volume":"628","author":"T Dyhring","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00702-014-1231-1","article-title":"The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene expression","volume":"121","author":"S Waters","year":"2014","journal-title":"J Neural Transm (Vienna)"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1093\/hmg\/ddw238","article-title":"Pridopidine activates neuroprotective pathways impaired in Huntington Disease","volume":"25","author":"M Geva","year":"2016","journal-title":"Hum Mol Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2016.10.006","article-title":"The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease","volume":"97","author":"D Ryskamp","year":"2017","journal-title":"Neurobiol Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0006-291X(03)00971-9","article-title":"Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia","volume":"306","author":"SL Anderson","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbrc.2005.08.054","article-title":"Tocotrienols reverse IKAP and monoamine oxidase deficiencies in familial dysautonomia","volume":"336","author":"SL Anderson","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bbrc.2003.09.019","article-title":"EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia","volume":"310","author":"SL Anderson","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrg3778","article-title":"Context-dependent control of alternative splicing by RNA-binding proteins","volume":"15","author":"XD Fu","year":"2014","journal-title":"Nat Rev Genet"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2777","article-title":"Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches","volume":"10","author":"M Chen","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1261\/rna.059428.116","article-title":"RBM24 promotes U1 snRNP recognition of the mutated 5' splice site in the IKBKAP gene of familial dysautonomia","volume":"23","author":"K Ohe","year":"2017","journal-title":"RNA"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"M Mottamal","year":"2015","journal-title":"Molecules"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1038\/cddis.2013.9","article-title":"HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses","volume":"4","author":"JE Bolden","year":"2013","journal-title":"Cell Death Dis"},{"key":"ref55","first-page":"135","article-title":"The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells","volume":"10","author":"MS Al-Keilani","year":"2018","journal-title":"Clin Pharmacol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.7314\/APJCP.2012.13.7.3471","article-title":"Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib","volume":"13","author":"QC Zhang","year":"2012","journal-title":"A549 cell line. Asian Pac J Cancer Prev"},{"key":"ref57","first-page":"355","article-title":"Sigma receptors: biology and function","volume":"42","author":"JM Walker","year":"1990","journal-title":"Pharmacol Rev"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","article-title":"The sigma-1 receptor chaperone as an inter-organelle signaling modulator","volume":"31","author":"TP Su","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jphs.2014.12.005","article-title":"Role of sigma-1 receptors in neurodegenerative diseases","volume":"127","author":"L Nguyen","year":"2015","journal-title":"J Pharmacol Sci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2014.09.022","article-title":"Sigma receptors as potential therapeutic targets for neuroprotection","volume":"743","author":"L Nguyen","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-319-50174-1_10","article-title":"Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection","volume":"964","author":"L Nguyen","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00213-014-3809-6","article-title":"Sigma 1 receptor activation regulates brain-derived neurotrophic factor through NR2A-CaMKIV-TORC1 pathway to rescue the impairment of learning and memory induced by brain ischaemia\/reperfusion","volume":"232","author":"Q Xu","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00424-017-1964-4","article-title":"Neurobiology of local and intercellular BDNF signaling","volume":"469","author":"M Sasi","year":"2017","journal-title":"Pflugers Arch"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrn2738","article-title":"TrkB signalling pathways in LTP and learning","volume":"10","author":"L Minichiello","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.1038\/ncomms9281","article-title":"TrkB\/BDNF signalling patterns the sympathetic nervous system","volume":"6","author":"JC Kasemeier-Kulesa","year":"2015","journal-title":"Nat Commun"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"CA Schneider","year":"2012","journal-title":"Nat Methods"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0211602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:21:34Z","timestamp":1588998094000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0211602"}},"subtitle":[],"editor":[{"given":"Emanuele","family":"Buratti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0211602","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/524587","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]}}}